Treatment Registry
TR-0464 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by Meto · Injection, vial · every compounded semaglutide record

What you actually pay

Per month

$228

Medication · GLP-1 family protocol$199
Required membership$29

Added from the figures recorded below.

Price

TermPer monthCharged today
GLP-1 family protocol

GLP-1 family Compounded semaglutide and tirzepatide for appetite regulation and metabolic reset. Same active ingredients as Ozempic, Wegovy, Mounjaro and Zepbound — priced without the commercial-pharma markup. $199/mo

source

Per month$199Charged today$199
Visit Meto

We earn nothing from this link. Meto has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
Cancellation“Can I cancel anytime? Yes — membership is month-to-month, and you can pause or cancel from your dashboard. No phone calls, no retention scripts.”
MembershipRequired. $29 per month. “Membership $29/month, billed at $320 annually. "Your membership unlocks clinician access and platform tools; peptide protocols are billed monthly based on the medication you're on", and the plan states "Cost of medication not included." ⛔ $29 × 12 is $348, so the annual price is a discount on the monthly rate rather than a restatement of it.”

Not yet checked: pharmacy, states and consult fee.

Recorded from meto.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Meto is a labs-first peptide platform; its 'GLP-1 family' protocol ($199/mo) is a single SKU covering EITHER compounded semaglutide (2.5 mg/mL) or tirzepatide (10 mg/mL) at the same price point, chosen by the clinician based on labs — not two separately priced products. On top of the $199/mo protocol price, every member also pays a separate $29/month membership fee that explicitly excludes medication cost, plus a one-time $149 lab panel required before matching to a protocol (not a recurring price, so not recorded as an entry).

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0464
Readings
1

Related records

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Meto compounded semaglutide (TR-0464). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0464

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.